On the other hand, taken together, to the best of our knowledge, insulin has a growing effect on cancer cells (57–59), therefore, the study mentioned above (4) may raise questions about how metformin’s improvement of insulin function at the cellular level could lead to anti-tumor effects on GBM cells. This evidence concerns the gene INS and glioblastoma.